Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
The results demonstrated meaningful reductions in the severity of involuntary movements and notable improvements in patient-reported quality of life
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
Venus Remedies now has 29 active product approvals in Vietnam alone
Sales from Novo’s GLP-1 portfolio—including Wegovy for obesity and Ozempic for type 2 diabetes reached $5.6 billion
This latest commitment brings the British pharmaceutical company’s total investment at the site to $886 million
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
Subscribe To Our Newsletter & Stay Updated
